Singapore: Patrys has received approval to commence its planned phase I/IIa multiple myeloma trial with lead anti-canc...
Singapore: Quest Diagnostics, a diagnostic information service provider, appointed Dr Sukumar Nagendran, as vice preside...
Singapore: The United Kingdom Science and Technology Committee has described the current lack of transparency of many c...
The rise of the National Key Economic Areas (NKEAs) has created a sense of urgency in Malaysia. The government, in its...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: To enhance its bioanalytical service offerings in Asia, Quintiles has signed an exclusive partnership with Bi...
Singapore: Australian company Clinuvel Pharmaceuticals reported successful, statistically significant results from its U...
Singapore: Japan-headquartered SymBio Pharmaceuticals has completed patient enrollment for its phase II clinical trial o...
Singapore: Vedic Lifesciences has successfully completed four human studies on sexual health, for various clients from C...
Singapore: Clinical Network Services (CNS), an Australian-based CRO offering integrated development services, has appoin...
Singapore: Charles River Laboratories is soon to acquire CRO services division of Galapagos, which includes both Argenta...
Singapore: INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R)...
Singapore: Australia, which celebrated International Clinical Trials Day on May 20, is looking to strengthen its clinica...
New Zealand has held a clean track record with early phase and proof of concept trials and has maintained accuracy in th...
The drug discovery outsourcing market will experience high revenue growth from 2013-to-2023. Expansion of the market wil...
Singapore: Prima BioMed, Australia's leading biotechnology company pioneering in therapeutic area of cancer is said to b...
Australia, known for providing rigorous high quality clinical research and enthusiastic investigators with centers of ...
Singapore: A phase III clinical trial of world leading breast cancer drug ABRAXANE (nanoparticle albumin-bound paclitax...
